Evidence map›Paper›PMID 41674641›Full record

ArticlemedRxiv : the preprint server for health sciences2026

From Awareness to ACTion Study: Improving Human Papillomavirus Knowledge, Screening, and Vaccine Uptake in Adolescent-Mother Pairs in the HOMINY study in Nigeria.

Oluwaseun Peter, Elohor Oborevwori, Esosa Osagie, Paul Akhigbe, Nosakhare L Idemudia, Ozoemene Obuekwe, Fidelis E Eki-Udoko, Nicholas Schlecht, Yana Bromberg, Nosayaba Osazuwa-Peters and 3 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Oluwaseun PeterInstitute of Human Virology Nigeria, International Research Centre of Excellence, Federal Capital Territory, Nigeria.
Elohor OborevworiJohns Hopkins School of Nursing, Johns Hopkins University, Baltimore, MD, United States.
Esosa OsagieInstitute of Human Virology Nigeria, International Research Centre of Excellence, Federal Capital Territory, Nigeria.
Paul AkhigbeInstitute of Human Virology Nigeria, International Research Centre of Excellence, Federal Capital Territory, Nigeria.
Nosakhare L IdemudiaUniversity of Benin Teaching Hospital, Medical Laboratory Services, Department of Medical Microbiology, Benin, Nigeria.
Ozoemene ObuekweUniversity of Benin, Department of Oral and Maxillofacial Surgery, Benin, Nigeria.
Fidelis E Eki-UdokoUniversity of Benin Teaching Hospital, Department of Child Health, Benin, Nigeria.
Nicholas SchlechtRoswell Park Comprehensive Cancer Center, Cancer Prevention and Control, New York, United States.
Yana BrombergEmory University, Department of Biology, Atlanta, United States.
Nosayaba Osazuwa-PetersDuke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, North Carolina, United States.ORCID 0000-0002-1390-9753
Praise O Okoh-AiheUniversity of Pennsylvania, Department of Basic and Translational Sciences, School of Dental Medicine, Philadelphia, United States.
Modupe O CokerInstitute of Human Virology Nigeria, International Research Centre of Excellence, Federal Capital Territory, Nigeria.
HOMINY Study Group

Funding

HPV, HIV and Oral Microbiota Interplay in Nigerian Youth (HOMINY)R01DE032216 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI MODUPE COKER, Nosayaba Osazuwa-Peters · 2022 to 2026
$4.5M
NIDCR NIH HHS R01 DE032216
6 · The paper itself

Abstract

Introduction: Persistent infection with high-risk Human Papillomavirus (hr-HPV) in women is a leading cause of cervical cancer, and its co-infection among people living with HIV (PLHIV) increases the risk of HPV-associated cancer, including oropharyngeal and anogenital cancers. In sub-Saharan Africa, awareness of HPV is limited, screening and vaccine adoption are critically low, undermining efforts toward sexually transmitted infection (STI) elimination. Methods: Results: At baseline, HPV awareness was low, with 34.5% of mothers and 1.4% of adolescents being aware of HPV. Post-sensitisation, awareness increased significantly to 64.4% and 19% in mothers and adolescents, respectively. Vaccination uptake rose from 0% to 3.4% in adolescents, and the proportion of mothers who underwent HPV-related screening (Visual Inspection with Acetic Acid and/or Papanicolaou test) increased from 38.7 % at baseline to 52.4 % after a year (p < 0.0001). Barriers to the adoption of preventive services included misconceptions, healthcare provider gaps, myths, misinformation, mistrust, skepticism, and limited access. Conclusions: HPV awareness programmes significantly improved knowledge, vaccination uptake, and screening practices in this vulnerable population. As part of comprehensive STI elimination strategies, integrating HPV education and vaccination initiatives into HIV care and research will enhance prevention and address significant barriers. Lessons from a unique programmatic science framework provide critical insights for scaling vaccine delivery, and the design of future vaccine programmes.

Indexed as

awarenesscancerHIVHuman papillomavirusscreeningvaccination

Identifiers

PMID41674641
PMCPMC12889748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.